Merck KGaA (OTCMKTS:MKKGY) Reaches New 1-Year Low – Time to Sell?

Merck KGaA (OTCMKTS:MKKGY)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $27.19 and last traded at $27.23, with a volume of 47833 shares traded. The stock had previously closed at $28.26.

Merck KGaA Price Performance

The firm has a 50 day moving average of $29.15 and a 200-day moving average of $31.05. The company has a current ratio of 1.33, a quick ratio of 0.91 and a debt-to-equity ratio of 0.28. The company has a market cap of $18.24 billion, a P/E ratio of 17.43, a P/E/G ratio of 2.05 and a beta of 0.98.

Merck KGaA (OTCMKTS:MKKGY) last released its quarterly earnings data on Thursday, March 6th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.07. Merck KGaA had a net margin of 12.89% and a return on equity of 10.41%. The firm had revenue of $5.78 billion for the quarter, compared to analysts’ expectations of $5.40 billion. On average, equities research analysts predict that Merck KGaA will post 1.87 EPS for the current year.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.